Diagnostics

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific

Partnership Delivers Advanced Radioligand Treatments Across Asia-Pacific, Expanding Access to Cutting-Edge Cancer Therapies TAIPEI, Taiwan, Jan. 09, 2025 (GLOBE NEWSWIRE)…

11 months ago

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific

Partnership Delivers Advanced Radioligand Treatments Across Asia-Pacific, Expanding Access to Cutting-Edge Cancer Therapies TAIPEI, Taiwan, Jan. 08, 2025 (GLOBE NEWSWIRE)…

11 months ago

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific

Partnership Delivers Advanced Radioligand Treatments Across Asia-Pacific, Expanding Access to Cutting-Edge Cancer Therapies TAIPEI, Taiwan, Jan. 09, 2025 (GLOBE NEWSWIRE)…

11 months ago

Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting

GERMANTOWN, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on…

11 months ago

Roche’s momentum in digital pathology continues with FDA clearance on its high-volume slide scanner

The VENTANA DP 600 slide scanner, part of Roche's Digital Pathology Dx system, is now cleared by the FDA to…

11 months ago

Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter

STONY BROOK, NY / ACCESSWIRE / January 8, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"),…

11 months ago

My Quest Story – James Murphy, Jr.

NORTHAMPTON, MA / ACCESSWIRE / January 8, 2025 / Quest Diagnostics I've only been at Quest Diagnostics for one year,…

11 months ago

DELFI Diagnostics to Participate in J.P. Morgan Healthcare Conference

Leader in liquid biopsy, cancer screening, and monitoring speaks at largest healthcare investment symposium BALTIMORE and PALO ALTO, Calif., Jan.…

11 months ago

Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer’s Disease

Largest DxA investment to date supports development of Alamar's ARGO™ DX System and future in vitro diagnostic tests NEW YORK…

11 months ago

TTG Imaging Solutions Rebrands as Catalyst MedTech, Strengthening Focus on Innovation in Nuclear Medicine and Molecular Imaging

PITTSBURGH, Jan. 8, 2025 /PRNewswire/ --  TTG Imaging Solutions, a leader in nuclear medicine and molecular imaging, announced a strategic…

11 months ago